IRTC iRhythm Technologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRTC

Price (delayed)

$83.155

Market cap

$2.54B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.27

Enterprise value

$2.61B

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based ...

Highlights
The company's gross profit rose by 30% YoY and by 5% QoQ
The EPS has increased by 26% YoY and by 5% from the previous quarter
The quick ratio has contracted by 35% YoY and by 13% from the previous quarter
IRTC's equity is down by 8% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.irhythmtech.com
Peers: MD

Key stats

What are the main financial stats of IRTC
Market
Shares outstanding
30.58M
Market cap
$2.54B
Enterprise value
$2.61B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
11.32
Price to sales (P/S)
5.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.77
Earnings
Revenue
$452.06M
EBIT
-$95.34M
EBITDA
-$79.97M
Free cash flow
-$50.33M
Per share
EPS
-$3.27
Free cash flow per share
-$1.65
Book value per share
$7.35
Revenue per share
$14.82
TBVPS
$14.05
Balance sheet
Total assets
$429.49M
Total liabilities
$205.61M
Debt
$129.28M
Equity
$223.88M
Working capital
$152.73M
Liquidity
Debt to equity
0.58
Current ratio
2.71
Quick ratio
2.41
Net debt/EBITDA
-0.85
Margins
EBITDA margin
-17.7%
Gross margin
68.9%
Net margin
-22%
Operating margin
-22.2%
Efficiency
Return on assets
-22.8%
Return on equity
-42.9%
Return on invested capital
-23.1%
Return on capital employed
-28%
Return on sales
-21.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
-2.14%
1 week
-11.07%
1 month
-20.29%
1 year
-30.17%
YTD
-11.23%
QTD
-20.29%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$452.06M
Gross profit
$311.53M
Operating income
-$100.16M
Net income
-$99.24M
Gross margin
68.9%
Net margin
-22%
The net margin is up by 39% YoY and by 9% from the previous quarter
IRTC's operating margin is up by 37% YoY and by 9% from the previous quarter
The company's gross profit rose by 30% YoY and by 5% QoQ
The revenue has grown by 25% YoY and by 5% from the previous quarter

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
11.32
P/S
5.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.77
The EPS has increased by 26% YoY and by 5% from the previous quarter
IRTC's P/B is 39% below its 5-year quarterly average of 19.1 and 21% below its last 4 quarters average of 14.6
IRTC's equity is down by 8% year-on-year
The P/S is 51% below the 5-year quarterly average of 11.8 and 29% below the last 4 quarters average of 8.1
The revenue has grown by 25% YoY and by 5% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
The ROS has increased by 40% YoY and by 11% from the previous quarter
IRTC's return on invested capital is up by 31% year-on-year and by 7% since the previous quarter
The ROA has grown by 21% YoY and by 5% from the previous quarter
iRhythm Technologies's ROE has increased by 13% YoY and by 3.2% from the previous quarter

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 109% greater than its total liabilities
The quick ratio has contracted by 35% YoY and by 13% from the previous quarter
The current ratio has declined by 33% year-on-year and by 13% since the previous quarter
The debt is 42% less than the equity
IRTC's equity is down by 8% year-on-year
The debt to equity has grown by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.